Mário L de Lemos

9PUBLICATIONS
14CO-AUTHORS
Food packaging, preservation and processingCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 27, 2025
Lactose intolerance or gastrointestinal adverse drug effect? guidance for oncology pharmacists.

Lisa Wanbon, Nadine Badry, Mário L de Lemos

|Sep 01, 2023
Utilization and toxicity patterns of 2-weekly (Q2W) versus 4-weekly (Q4W) nivolumab for treatment of adjuvant and metastatic melanoma at BC cancer.

Jennifer Truong, Shirley S T Yeung, Victoria Kletas

|Apr 06, 2022
International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions.

Andrew Walker, Alexandre Chan, Constanza Cortés Labra

|Mar 07, 2022
Real-world incidence of venetoclax toxicities in British Columbia.

Cassandra Lee, Adeline Markarian, Fatima Ladha

|Sep 24, 2021
Defining cytotoxic drugs - you know it when you see it?

Mário L de Lemos, Nadine Badry, James Conklin

|Apr 10, 2020
International Society of Oncology Pharmacy Practitioners global position on the use of biosimilars in cancer treatment and supportive care.

Morgan B Frazer, Joseph Bubalo, Himanshu Patel

Pageof 2

Frequent Collaborators

3 joint publications

Lynne Nakashima

2 joint publications

Victoria Kletas

1 joint publications

Vian Cheng

1 joint publications

Himanshu Patel